Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 626 across all filing types
Latest filing 2024-01-23 Major Shareholding Noti…
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-23 English
6-K
Regulatory Filings
2024-01-22 English
6-K
Regulatory Filings
2024-01-08 English
QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
Share Issue/Capital Change Classification · 99% confidence The document is an 'Ad hoc Announcement' detailing a plan to return approximately $300 million to shareholders via a 'synthetic share repurchase' involving a capital repayment and a reverse stock split. This action directly relates to the company's share structure and capital management. Based on the definitions, this falls under 'Share Issue/Capital Change' (SHA) or 'Transaction in Own Shares' (POS). Since the primary mechanism described is a capital repayment combined with a reverse stock split intended to return cash (a form of capital management/return), and it explicitly mentions the mandate approved at the AGM, it strongly aligns with capital structure changes. However, the specific action of returning capital via a repurchase mechanism is best classified as 'Transaction in Own Shares' (POS), which covers share repurchases. Alternatively, 'Capital/Financing Update' (CAP) is also plausible, but POS is more specific to share buybacks/returns. Given the description of a synthetic share repurchase, POS is the most precise fit.
2024-01-08 English
SEC SCHEDULE 13G
Major Shareholding Notification
2023-12-06 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by QIAGEN N.V. It contains a comprehensive quarterly report (Exhibit 99.1) for the period ended September 30, 2023, including condensed consolidated financial statements (balance sheets, income statements, cash flows, and notes). Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2023
2023-11-01 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.